Literature DB >> 9428662

Proteolysis of Alzheimer's disease beta-amyloid precursor protein by factor Xa.

C Haas1, J Aldudo, P Cazorla, M J Bullido, C de Miguel, J Vázquez, F Valdivieso.   

Abstract

Amyloid beta-protein is a 4-kDa peptide which originates from proteolysis of a larger protein precursor (APP) and accumulates in senile plaques in brains of Alzheimer's disease (AD) patients. Since secreted APP inhibits factors IXa, Xa and XIa, and thrombin appears to play a role in APP secretion and proteolysis, a relationship between hemostasis system and APP metabolism seems to exist. In this work we investigate the susceptibility to proteolytic cleavage by factor Xa of a fusion construct containing full-length APP prepared in bacteria, and demonstrate that both APP695 and APP770 are substrates for this protease. Factor Xa was found to cleave APP after arginines 102, 268, 510, 573 and 601 (APP695 numeration); most of these sites appear to be common for different coagulation factors. In addition, APP incubation with factor Xa generates an array of six potentially amyloidogenic fragments. Comparative kinetic analysis of APP695 and APP770 cleavage by factor Xa suggests that Kunitz-type inhibitor-containing isoforms exert an inhibitory effect on the protease. However, this inhibition is far from complete even at a 5-fold molar excess of inhibitor. Our results raise the possibility that proteases from the coagulation cascade may contribute to APP proteolysis, and support the notion that these proteases play a role in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428662     DOI: 10.1016/s0167-4838(97)00094-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's disease.

Authors:  P Lewczuk; J Wiltfang; M Lange; H Jahn; H Reiber; H Ehrenreich
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 2.  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Authors:  Kumar Sambamurti; Nigel H Greig; Debomoy K Lahiri
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 3.  Heparin oligosaccharides as potential therapeutic agents in senile dementia.

Authors:  Qing Ma; Umberto Cornelli; Israel Hanin; Walter P Jeske; Robert J Linhardt; Jeanine M Walenga; Jawed Fareed; John M Lee
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.